Kisspeptin isn\u2019t like other peptides. It\u2019s what starts the whole hormonal cascade \u2014 the hypothalamic-pituitary-gonadal axis itself. Its signal has to be precise. Flawless. CellPeptides is the EU-based research and scientific company you can always rely on for pharmaceutical-grade peptides that make exciting scientific discoveries possible.<\/p>\n
Our Kisspeptin-10 is:<\/p>\n
We accept bank transfers, credit cards, and crypto. Because we don\u2019t think payment methods or data privacy concerns should have to get in the way of your research. And if you need research support or have questions about ordering? Just ask our customer service team. We\u2019re peptide nerds, just like you.<\/p>\n
The synthetic version of Kisspeptin-10 is an exact copy of the natural form \u2014 and it works the same way.<\/p>\n
The KISS1 gene makes a large precursor protein with as many as 145 amino acids. Enzymes turn it into a series of much smaller kisspeptins, including Kisspeptin-10. It\u2019s not the only relevant kisspeptin, but it\u2019s the smallest sequence that can bind to the GPR54 receptor. Once it does, GnRH pulses start firing. That process, in turn, gets the body to release LH and FSH, without which neither fertility nor a healthy sex drive is possible.<\/p>\n
The scientific potential of synthetic Kisspeptin-10 is immediately apparent. It\u2019s already used clinically to diagnose fertility challenges \u2014 but potential future applications are even more interesting. Let\u2019s go there next.<\/p>\n
Kisspeptin-10 has become one of the most fascinating neuroendocrine regulators in the body in research settings. It\u2019s the smallest but most active fragment of the kisspeptin protein. As such, it\u2019s pretty exclusive. It\u2019s the switch that turns the GPR54 receptor on, the peptide without which\u00a0 Gonadotropin-Releasing Hormone stops.<\/p>\n
That, of course, makes studying it worthwhile \u2014 far outside of its original discovery setting, cancer metastasis. What directions has this research taken since scientists first synthesized Kisspeptin-10 in the 1990s? See for yourself.<\/p>\n
It\u2019s the main trigger for the HPG axis, so it\u2019s no surprise that researchers have been curious to find out if Kisspeptin-10 could potentially serve as a more sophisticated answer to direct hormone replacement therapy. It can, in that Kisspeptin-10 boosts LH and FSH production, which can then kick the body\u2019s natural testosterone or estrogen production up a few notches. [1<\/a>, 2<\/a>]\n That makes Kisspeptin ripe for further research into hypogonadism \u2014 reduced sex hormone production \u2014 with a myriad of different underlying causes, from sports medicine to menopause and the age-related hormonal decline people run into so much frustration with.<\/p>\n More than eight million children have already been born thanks to IVF, but it\u2019s no secret that this assisted reproductive technology isn\u2019t risk-free. The risk of Ovarian Hyperstimulation Syndrome, a dangerous side effect, in HCG cycles is well known. What if Kisspeptin-10 could be used for oocyte maturation instead, without the same risk? Research has already looked at this exciting possibility, with interesting results. [3<\/a>] With further study, the future of IVF might become a lot safer.<\/p>\n The HPG axis doesn\u2019t only have a direct impact on mood and energy \u2014 more about that later \u2014 but also on sex drive. Animal studies are actively figuring out how exogenous Kisspeptin-10 influences the regions of the brain responsible for libido. [4<\/a>] This effect is logical when you think about it. The restoration of healthy, normal, youthful sex hormone levels clearly has the potential to impact desire and motivation.<\/p>\n A direct follow-on \u2014 because the same mood and energy boosts that get a beaten-down libido started up again also have a much wider impact on mental states. So far, early research has demonstrated that Kisspeptin-10 has anti-depressive, anxiety-fighting effects in animal models \u2014 and that it helps to restore energy levels. [5<\/a>, 6<\/a>]\n Two birds, one stone? Almost. Researchers have been looking into the mood-improving potential of Kisspeptin-10 mostly in the context of psychosexual disorders. That is, disorders wherein depression and anxiety are inherently linked to low libido and in some cases infertility. Could there be wider mental health uses for Kisspeptin-10? Future studies are sure to investigate this possibility.<\/p>\n Surprised? Early researchers were, too. Kisspeptin receptors are, in fact, found in the pancreas among other places \u2014 and that made scientists wonder if it could play a role in blood sugar stabilization and insulin sensitivity improvements, too. [7<\/a>]\n Animal models say \u201cyes.\u201d Intravenous Kisspeptin-10 administration boosts glucose tolerance, circulating insulin levels, and other metabolic health markers. The relationship between sexual and metabolic health is deeper than once thought, this already suggests. [8<\/a>] Future research is bound to make even more breakthroughs.<\/p>\n The original use case, metastasis inhibition, hasn\u2019t been left in the dust just because research has revealed viable applications in completely different fields. Kisspeptin slows down or stops the cell migration that makes metastasis possible, especially in cases of breast cancer and melanoma \u2014 and scientists don\u2019t yet know why that\u2019s true. [9<\/a>] Research remains in its preclinical phase, but follow this area closely, even if you\u2019re primarily interested in studying other applications.<\/p>\n It\u2019s quite literally at the top of the neuroendocrine cascade \u2014 so the fact that researchers across fields are drawn to the study of Kisspeptin-10 makes perfect sense. The applications with the biggest hope of medium-term clinical use? They include:<\/p>\n Kisspeptin-10 might very well be a missing link in these areas. Your next discovery starts with research-grade Kisspeptin-10 from CellPeptides.<\/p>\n Kisspeptin-10 research is exploding \u2014 but because the peptide has so many different applications in so many different fields of research, dosing protocols are also highly dependent on the goal of the study and the model. That\u2019s true more than with many other peptides.<\/p>\n In animal models, doses of 150-300 mcg (subQ or IV) are not uncommon for research that studies natural GnRH pulses. Longer term studies that investigate metabolic effects more often rely on dosing from 300-500 mcg. Sex, weight, and species also matter.<\/p>\n Prepare Kisspeptin-10 for studies with multi-dose applications like this. Tap the vial to settle the dry peptide, inject bacteriostatic water slowly (2 mL for a 5 mg vial usually), pointing the stream at the vial wall. Then swirl the vial. Once the solution is clear, it\u2019s safe to store between 2 and 8 \u00b0C, conditions that generally keep it stable for a maximum of 30-60 days.<\/p>\n Regarding the dosage calculation – we have a handy tool — peptide dosage calculator<\/a>. Feel free to use it if you need it.<\/p>\n How does Kisspeptin-45 differ from Kisspeptin 10?<\/strong><\/p>\n Kisspeptin-45 is the full-length peptide. It has a significantly longer half-life \u2014 but it\u2019s hard to synthesize and therefore much more expensive to use in research. Kisspeptin-10 is the shortest biologically active fragment. It has the same practical effects, but at a much lower cost.<\/p>\n What effect does Kisspeptin-10 have on male libido? Does it increase testosterone?<\/strong><\/p>\n Studies are actively looking at the effect Kisspeptin-10 has on libido. It is, however, well-established that the peptide leads to a tangible testosterone boost in male test subjects. This boost is indirect, via GnRH release.<\/p>\n How quickly can the effects of Kisspeptin-10 be observed in studies?<\/strong><\/p>\n Expect a hormonal response very quickly \u2014 within 45 minutes. Functional impacts on metabolism and physiological processes linked to sex hormones take longer, days to weeks.<\/p>\n Kisspeptin-10<\/strong> si je ustvaril(a) sloves spodbujevalnika libida, niste edini, ki ste morda potegnili kak\u0161ne zaklju\u010dke o izvoru imena. A ne, Kisspeptin-10 se tako imenuje, ker je bil gen KISS1 prvi\u010d odkrit v Hersheyju v Pensilvaniji \u2013 kot mo\u010dan zaviralec metastaz raka.<\/p>\n Zgodnje korenine tega peptida segajo v raziskave raka, vendar je njegova \u0161ir\u0161a obetavnost bolj povezana z dejstvom, da je glavni spro\u017eilec za spro\u0161\u010danje GnRH<\/strong>, endokrino \u201cstikalo\u201d, ki spro\u017ei celotno hipotalami\u010dno-hipofizno-gonadalno os. Zaradi te nadzorne in krmilne vloge ima kisspeptin-10 neskon\u010den raziskovalni potencial \u2013 za spro\u017eitev ovulacije v protokolih plodnosti, pri motnjah pubertete, presnovnih funkcijah, libidu in hormonskem ravnovesju.<\/p>\n Med najbolj vznemirljivimi nastajajo\u010dimi podro\u010dji \u0161tudija? Je del boja proti staranju (hormonski upad je morda manj neizogiben, kot se je neko\u010d mislilo?) in njegov vpliv na razpolo\u017eenje.<\/p>","protected":false},"featured_media":1003,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[16],"product_tag":[],"class_list":["post-844","product","type-product","status-publish","has-post-thumbnail","product_cat-uncategorized","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"yoast_head":"\nFertility and Reproductive Health Research<\/h3>\n
Kisspeptin-10 Research Into Libido Improvement and Sexual Health<\/h3>\n
Improved Mood and Energetic Balance<\/h3>\n
The Metabolic Health Uses of Kisspeptin-10<\/h3>\n
Kisspeptin-10 and Cancer Metastasis Suppression<\/h3>\n
Who Might Consider Researching Kisspeptin-10?<\/h2>\n
\n
Common Dosing Protocols for Kisspeptin-10 In-Vitro Research Setting<\/h2>\n
FAQs<\/h2>\n
Scientific References<\/em><\/h2>\n
\n